000487673 000__ 01506cam\a2200373Ia\4500
000487673 001__ 487673
000487673 005__ 20210513171502.0
000487673 006__ m\\\\\o\\d\\\\\\\\
000487673 007__ cr\cn|||||||||
000487673 008__ 090731s2010\\\\nyua\\\\ob\\\\001\0\eng\d
000487673 010__ $$z  2009031817
000487673 020__ $$z9781612093680
000487673 020__ $$z9781607415657 (hardcover)
000487673 020__ $$z1607415658 (hardcover)
000487673 035__ $$a(CaPaEBR)ebr10662759
000487673 035__ $$a(OCoLC)699510130
000487673 040__ $$aCaPaEBR$$cCaPaEBR
000487673 05014 $$aRJ560$$b.S24 2010eb
000487673 08204 $$a615/.190083$$222
000487673 24500 $$aSafety efforts in pediatric drug development$$h[electronic resource] /$$cConor D. Byrne, editor.
000487673 260__ $$aNew York :$$bNova Science Publishers,$$cc2010.
000487673 300__ $$axiv, 133 p. :$$bill.
000487673 4901_ $$aPharmacology--research, safety testing and regulation series
000487673 504__ $$aIncludes bibliographical references and index.
000487673 506__ $$aAccess limited to authorized users.
000487673 61010 $$aUnited States.$$tBest Pharmaceuticals for Children Act.
000487673 650_0 $$aPediatric pharmacology$$zUnited States.
000487673 650_0 $$aPediatrics$$zUnited States$$xFormulae, receipts, prescriptions$$xSafety measures.
000487673 650_0 $$aDrug development$$zUnited States$$xSafety measures.
000487673 7001_ $$aByrne, Conor D.
000487673 830_0 $$aPharmacology-research, safety testing, and regulation series.
000487673 852__ $$bebk
000487673 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10662759$$zOnline Access
000487673 909CO $$ooai:library.usi.edu:487673$$pGLOBAL_SET
000487673 980__ $$aEBOOK
000487673 980__ $$aBIB
000487673 982__ $$aEbook
000487673 983__ $$aOnline